Husker research duo selected as Phase 1 winners in the NIH’s Targeted Genome Editor Delivery Challenge

A Husker research duo was named a first-round winner in a National Institutes of Health competition aimed at generating solutions for delivering genome-editing technology to the cells of people with rare and common diseases.

Introducing Motion: Real-Time Motion Insights for Aging in Place

What You Should Know: – Threshold Care Inc., a company committed to empowering caregivers with essential insights about their aging loved ones, announces the availability of

October 10, 2024

Cell therapy startup ArsenalBio raises $325M as it runs early solid tumor trials

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 5, 2024

Canadian Cannabis Sales Pick Up Strongly in June

Statistics Canada released June retail sales for the country, with cannabis sales rising from the May levels, up 2.6% to C$426.6 million, a new record for a

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.